Citigroup Inc. logo

Citigroup Inc.

C | NYSE
Chart Builder DCF Calculator
$134.31
+$2.53 (+1.92%)
Sep 21, 2026, 12:44 PM ET · Market open
+1.92%

Rating

Updated: Aug 28, 2026
49.2
Fundamentals Average
Market Sentiment Neutral
Moat None

Why Price Moved

4 days ago
-2.36%

Shares are trading lower amid investor concerns re...

Key Statistics

Market Data

Market Cap $230.33B
1D Range
132.62 134.48
52W Range
93.66 147.96

Valuation (TTM)

PE 14.23
PB 1.07
EV/EBITDA 9.35

Valuation (NTM)

Forward PE 9.44
Forward PEG 0.97
Price Target $150.18
Loading financial charts...

Profile

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal B...

Employees 219,000
IPO Date Jan 2, 1977
Fiscal Year January - December

Latest News

Citi CEO Sees ‘Tsunami' of Patching to Secure AI Defense

7 hours ago · youtube.com

Citi CEO Sees ‘Tsunami' of Patching to Secure AI Defense

Citigroup CEO Jane Fraser said that companies are racing to build up their defenses on artificial-intelligence models. Speaking on the AI revolution, Fraser said when Mythos came out, “that was not a good day.

Citi CEO Says Companies Scrambling to Launch AI Cyber Defenses

20 hours ago · pymnts.com

Citi CEO Says Companies Scrambling to Launch AI Cyber Defenses
C's Banamex Exit Nears Deconsolidation: Is $9B Charge Concerning?

5 days ago · zacks.com

C's Banamex Exit Nears Deconsolidation: Is $9B Charge Concerning?
Citigroup Lifts 2026 ROTCE Outlook Above 11%: What's Driving the Gain?

6 days ago · zacks.com

Citigroup Lifts 2026 ROTCE Outlook Above 11%: What's Driving the Gain?
Citigroup Sees ROTCE Beating Guidance as Markets, Cards and Services Gain

6 days ago · marketbeat.com

Citigroup Sees ROTCE Beating Guidance as Markets, Cards and Services Gain
Should You Buy Citigroup Stock as It Jumps 29.3% in 6 Months?

7 days ago · zacks.com

Should You Buy Citigroup Stock as It Jumps 29.3% in 6 Months?
Maze Therapeutics, Inc. (MAZE) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

11 days ago · seekingalpha.com

Maze Therapeutics, Inc. (MAZE) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
SpyGlass Pharma, Inc. (SGP) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

11 days ago · seekingalpha.com

SpyGlass Pharma, Inc. (SGP) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript
C Pushes Tokenized Deposits Deeper Into Asia With Japan Expansion

11 days ago · zacks.com

C Pushes Tokenized Deposits Deeper Into Asia With Japan Expansion
4 Thriving Investment Bank Behemoths to Buy With Attractive Valuation

11 days ago · zacks.com

4 Thriving Investment Bank Behemoths to Buy With Attractive Valuation

Earnings

Next Earnings
Oct 13, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
15
Consensus
Buy
Price Target
$150
Upside
+11.68%
Buy (11)
Hold (3)
Sell (0)
Analyst Details

© 2026 bestshares.com. All rights reserved.